EFFECTIVENESS OF MODERN METHODS OF TREATING TYPE I MUCOPOLYSACCHARIDOSIS PATIENTS
Type I mucopolysaccharidosis (MPS) is a hereditary metabolic disease related to lysosomal storage diseases. Alpha-L-iduronidase enzyme deficiency leads to dissimilar disease phenotypes and varying severity of symptoms. Researchers distinguish between three phenotypes of the disease: Hurler syndrome...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Russo |
| Wydane: |
Union of pediatricians of Russia
2014-11-01
|
| Seria: | Педиатрическая фармакология |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.pedpharma.ru/jour/article/view/40 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
